Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00998023 · ClinicalTrials.gov registry record · NA
Patient Comfort With Vascular Closure
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT00998023 is a NA study that has completed, run by University of Florida. The registered enrollment target is 64 participants.
The verdict
NCT00998023, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vascular Closure Device and the Angio-Seal Evolution Vascular Closure Device.
Interventions
- DEVICE Mynx Vascular Closure Device
- DEVICE AngioSeal Vascular Closure Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00998023
The ClinicalTrials.gov registry entry for NCT00998023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mynx Vascular Closure Device is the first listed.
NCT00998023 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00998023 about?
NCT00998023 is a clinical study titled "Patient Comfort With Vascular Closure". The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vascular Closure Device and the Angio-Seal Evolution Vascular Closure Device.
What is the current status of trial NCT00998023?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2009-10. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00998023?
The interventions under investigation include: Mynx Vascular Closure Device (DEVICE), AngioSeal Vascular Closure Device (DEVICE).
Who is sponsoring clinical trial NCT00998023?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.